News
34m
Stockhead on MSNHealth Check: Neuren says the US Rett syndrome market is a case of glass half full
Neuren Pharmaceutical's partner Acadia reports boosted sales of the Rett syndrome drug Daybue, but Neuren notes two-thirds of ...
People with a wheat or soy allergy could experience a "serious or life-threatening" reaction if they consume the product.
Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and ...
Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...
Orthofix Medical’s 2025 sell-off presents a value opportunity, says Rewey Asset Management. Learn why insiders are buying and ...
Baker Mayfield addressed the NFL’s 2025 smelling salts ban with sarcasm and hinted at a surprising new game day energy boost.
Tucked in your cheek, these tiny pouches deliver caffeine directly to your bloodstream. Here’s what to know before you try this nootropic supplement.
The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...
MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...
U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...
Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.
Discover the truth about parasite cleanses trending on social media. Learn about parasitic infections, symptoms, FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results